The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond
Files
Publication date
2018-04-01
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Mutations in the PSTPIP1 gene encoding proline-serine-threonine-phosphatase interactive protein 1 were first identified in an autosomal dominant syndrome called PAPA associated with pyogenic sterile arthritis, pyoderma gangrenosum (PG) and cystic acne.1,2 . We report a patient with an autoinflammatory syndrome called PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.3 A 23-year-old man had a 3-year-history of skin ulcerations. This article is protected by copyright. All rights reserved.
Keywords
Taverne, Dermatology
Citation
Klötgen, H W, Beltraminelli, H, Yawalkar, N, van Gijn, M E, Holzinger, D & Borradori, L 2018, 'The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations : from PAPA to PAMI syndrome and beyond', British Journal of Dermatology, vol. 178, no. 4, pp. 982-983. https://doi.org/10.1111/bjd.16136